Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level, supporting targeted treatment development. The company’s approach integrates biology, engineering, and chemistry to streamline the drug discovery process. Through its proprietary platforms, Eikon Therapeutics seeks to advance clinical programs and expand its pipeline of potential medications.
Domain
eikontx.com
Country
United StatesIndustry
BiotechnologyEmployees
251-500
Last Funding
$350.7M
Founded
2018
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Eikon Therapeutics use?+
Eikon Therapeutics uses 19 technologies including Google Analytics, Google Tag Manager, Mouse Flow.
What industry is Eikon Therapeutics in?+
Eikon Therapeutics operates in the Biotechnology industry.
Where is Eikon Therapeutics based?+
Eikon Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026